Tag: Ed Silverman
FDA Memo Rebuffs Many Suggestions for Expanding Off-label Marketing
"After weeks of anticipation, the FDA has issued a lengthy memo about the extent to which so-called off-label information about medicines may be disseminated...
âDoes the FDA have a High Enough Standard for Drug Approvals?â
Last week STAT hosted a panel of experts, asking âIs the Food and Drug Administrationâs approval process broken?â
Article âÂ
âWhy We Shouldnât Trade a Weakened FDA for More Medical Research...
Ed Silverman at STAT reports that Congress has linked increased research funding to âfast-trackâ approval procedures. âBy linking the extra funds to speedier approvals,...
